Scott Lee

Appearances

EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION THERAPY IN CROHN’S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL
Date
May 9, 2023
BACKGROUND: After successful induction, a subset of patients with Crohn’s disease (CD) experience a secondary loss of response (LoR) to ustekinumab (UST) maintenance therapy. Dose intensification may assist in regaining response…
Presenter
Scott Lee
Speakers
Stefan Schreiber
Christien Janneke Van Der Woude
Ignacio Marin-Jimenez
Douglas Wolf
Elisabeth Schnoy
Bruce Salzberg
Christopher Busse
Maciej Nazar
Wayne Langholff
Stephan Borghorst
Christopher Gasink
Thomas Baker
Bridget Godwin
Brian Feagan